Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
Submitted by
admin
on August 13, 2015 - 2:47pm
Source:
Bizjournals.com
News Tags:
FDA
BioDelivery Sciences
Onsolis
cancer pain
breakthrough pain
Headline:
With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
Do Not Allow Advertisers to Use My Personal information
